Clinical Trial Update: XIENCE V: SPIRIT WOMEN Sub-study [Phase 4]

View source ↗

Summary

Phase 4 SPIRIT WOMEN sub-study updating results for the XIENCE V everolimus-eluting coronary stent; the study completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Arteriosclerosis
• Coronary Artery Disease
• Coronary Artery Stenosis
• Coronary Restenosis
• Myocardial Ischemia
• Stent Thrombosis
• Total Occlusion of Coronary Artery
• Vascular Disease

Drugs mentioned

• XIENCE V (everolimus-eluting stent)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Artery Stenosis, Coronary Arteriosclerosis | Phase 4 | Status: COMPLETED | Results posted: 2012-07-13